Helix BioPharma (TSX:HBP) FCF Yield % : -13.61 (As of May. 25, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Helix BioPharma's Trailing 12-Month Free Cash Flow is C$-6.40 Mil, and Market Cap is C$47.04 Mil. Therefore, Helix BioPharma's FCF Yield % for today is -13.61%.

The historical rank and industry rank for Helix BioPharma's FCF Yield % or its related term are showing as below:

TSX:HBP' s FCF Yield % Range Over the Past 10 Years
Min: -133.92 Med: -25.58 Max: -9.69
Current: -13.61

During the past 13 years, the highest FCF Yield % of Helix BioPharma was -9.69%. The lowest was -133.92%. And the median was -25.58%.

TSX:HBP's FCF Yield % is ranked better than
51.38% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs TSX:HBP: -13.61

Helix BioPharma's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.

Helix BioPharma FCF Yield % Historical Data

The historical data trend for Helix BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma FCF Yield % Chart

Helix BioPharma Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Yield %

Get a 7-Day Free Trial

-8.91

-15.10

-7.94

-19.94

-12.17

Helix BioPharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Yield %	Get a 7-Day Free Trial															-9.96	-14.67	-13.55	-15.64	-14.52

Competitive Comparison of Helix BioPharma's FCF Yield %

For the Biotechnology subindustry, Helix BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's FCF Yield % falls into.

Helix BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Helix BioPharma's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-5.537	/	45.50154
	=	-12.17%

Helix BioPharma's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.494	*	4	/	41.16806
	=	-14.52%

Helix BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Helix BioPharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Helix BioPharma (TSX:HBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

HBPCF:USA

Address

401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y

Website

https://www.helixbiopharma.com

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.